Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC010645

Drug Information
Name(R)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate
IndicationNot AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C11H19N3O2/c1-3-9(2)14-11(15)16-6-4-5-10-7-12-8-13-10/h7-9H,3-
6H2,1-2H3,(H,12,13)(H,14,15)/t9-/m1/s1
InChIKeyRSHJCGZZSGNBHO-SECBINFHSA-N
Canonical SMILESCCC(C)NC(=O)OCCCC1=CN=CN1    
Isomeric SMILESCC[C@@H](C)NC(=O)OCCCC1=CN=CN1
TargetHistamine H3 receptorInhibitor[1]
Histamine H4 receptorInhibitor[1]
Ref 1Bioorg Med Chem Lett. 2009 Dec 1;19(23):6682-5. Epub 2009 Oct 6.Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543